Rankings
▼
Calendar
CRIS Q1 2016 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena
CRIS
Curis, Inc.
$14M
Q1 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
Gross Profit
$2M
94.9% margin
Operating Income
-$9M
-510.3% margin
Net Income
-$9M
-547.0% margin
EPS (Diluted)
$-7.32
QoQ Revenue Growth
-17.5%
Cash Flow
Operating Cash Flow
-$8M
Free Cash Flow
-$8M
Stock-Based Comp.
$772,079
Balance Sheet
Total Assets
$85M
Total Liabilities
$29M
Stockholders' Equity
$56M
Cash & Equivalents
$15M
Revenue Segments
Drug Development Royalty
$124,162
100%
← FY 2016
All Quarters
Q2 2016 →